[144] Zai Lab Ltd SEC Filing
Zai Lab Ltd (ZLAB) filed a Form 144 reporting a proposed sale of 456 American Depositary Shares (ADS) with an aggregate market value of $15,616.6810/02/2025 through Fidelity Brokerage Services on NASDAQ. The ADS were acquired on 10/01/2025 via restricted stock vesting and were paid as compensation. The filer also disclosed two prior sales in the last three months: 4,096 ADS sold on 08/08/2025 for $139,304.96 and 1,438 ADS sold on 08/15/2025 for $50,931.59. Total shares outstanding reported are 421,725,450. The filing includes the standard representation that the seller is unaware of any undisclosed material adverse information.
- Disclosure compliance: Form 144 filed and includes acquisition, sale dates, amounts, and broker information
- Source of shares disclosed: 456 ADS were acquired via restricted stock vesting and paid as compensation
- Insider selling activity: 5,534 ADS sold in the past three months for total gross proceeds of $190,236.55
- Small transaction relative to shares outstanding: While disclosed, the proposed 456 ADS represent a very small fraction of the 421,725,450 outstanding shares
Insights
TL;DR: Insider plans to sell a small block of ADS after recent vesting; prior open-market sales were disclosed.
The filing shows the sale arises from newly vested restricted ADS reported as compensation on 10/01/2025, with a proposed sale of 456 ADS on 10/02/2025 through Fidelity. The filer also disclosed two open-market sales in August totaling 5,534 ADS and roughly $190,236 in gross proceeds. These disclosures meet Rule 144 notice requirements and provide transparent timing and proceeds for investor review.